Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Open accessThe DOI matches its Crossref record; 340 of the 344 references it cites were found in a registry or an index.
Abstract
Patients with type 2 diabetes mellitus (T2DM) are at high risk for macrovascular complications, which represent the major cause of mortality. Despite effective treatment of established cardiovascular (CV) risk factors (dyslipidemia, hypertension, procoagulant state), there remains a significant amount of unexplained CV risk. Insulin resistance is associated with a cluster of cardiometabolic risk factors known collectively as the insulin resistance (metabolic) syndrome (IRS). Considerable evidence, reviewed herein, suggests that insulin resistance and the IRS contribute to this unexplained CV risk in patients with T2DM. Accordingly, CV outcome trials with pioglitazone have demonstrated that this insulin-sensitizing thiazolidinedione reduces CV events in high-risk patients with T2DM. In this review the roles of insulin resistance and the IRS in the development of atherosclerotic CV disease and the impact of the insulin-sensitizing agents and of other antihyperglycemic medications on CV outcomes are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, as the MAPK pathway has normal sensitivity to insulin, hyperinsulinemia activates the MAPK pathway, promoting vascular smooth muscle cell growth and activating inflammatory pathways, such as IkB/NF-kB and JNK [107,108].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [108]
In the citing paper
“These macrophages, in combination with adipocytes and lipid-infiltrated muscle tissues, stimulate the secretion of proinflammatory cytokines, particularly TNF-α and IL-6, while reducing the release of protective adiponectin, thereby evoking systemic chronic inflammation that directly damages the vascular endothelium and, in, turn exacerbates IR and atherosclerosis (56).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [56]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Research works printed but not linked: 1
- Hsueh, 1999, Insulin signals in the arterial wall, J Cardiol, 84, 21, 10.1016/S0002-9149(99)00353-7 · DOI · Paper page
Cited by
Items 301–400 of 535
Unveiling the Significance of Surrogate Markers of Insulin Resistance in Metabolic Health Assessment
Prashant, A., Nataraj, S. M., Swetha, N., Gowda, J., Najmunnissa, F., & Guruswamy, K. M. (2024) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0227 · Cited by 3
“15 Insulin resistance can result in increased sympathetic nervous system activity and sodium retention, both of which contribute to hypertension.”
BackgroundGong, C., Chen, C., Zhao, Y., Wang, Y., Li, K., Lv, X., Guo, X., Ma, D., Zhai, X., Han, M., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02391-1 · Cited by 3
“…a reliable non-insulin-based alternative parameter for evaluating IR in patients with T2D, which is closely linked to the visceral fat area (VAI) and ASCVD progression, and may even serve as the best IR parameter for predicting prognosis after complex percutaneous coro - nary intervention [13].”
Deng, S., Lv, S., Liu, Y., Xu, H., Yin, H., Xiao, B., Wang, S., Lü, D., Li, Y., & Wang, X. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s492973 · Cited by 3
“Additionally, insulin resistance, 26,27 myokines, 28–30 oxidative stress and inflammation, 31,32 and changes in sex hormone levels 33–35 might also play roles.”
BackgroundFormisano, E., Vignati, A., Bertolini, A., Barreto, V. S., Tafuro, M., Pasta, A., Sukkar, S. G., & Pisciotta, L. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.06.018 · Cited by 5
Delsart, P., Lemaître, M., Vambergue, A., Ninni, S., Bauters, C., Ledieu, G., Eymard, D.-F., Baudoux, F., Preville, A. L. C. D., Sobocinski, J., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01879-y · Cited by 3
Huan, D. E. N. G., Zhou, S., Wang, X., Qiu, X., Wen, Q., Liu, S., & Chen, Q. (2020) · Medicine · doi:10.1097/md.0000000000020462 · Cited by 3
Zhao, X., Wang, J., Li, Q., Ye, Y., & Zeng, Y. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07272-1 · Cited by 4
Schmiedt, R. A., Tiucă, R. A., Tilinca, R. M., Custură, L. M., Deteșan, O., Bacso, B. I., Abalasei, B. L., Bell, A. C., Streza, M. A., & Tilinca, M. C. (2021) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2021-0033 · Cited by 5
Liu, M., Xiang, S., & Hu, X. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i8.108839 · Cited by 3
Zhang, F., Wang, Z., Zhang, H., & Zuo, Y.-Q. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1696652 · Cited by 3
Panhuis, W. I. H., Thiemann, E., van Dijk, D. M. A. H., Been, B., Jarrett, K. E., Meurs, A., Kooijman, S., Hovingh, M. V., Modder, M., van Os, B. W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx3794 · Cited by 2
Zhu, Y., Wang, Y., Zhang, G., Ma, F., Xia, J.-X., Lian, H., Cao, Y., Zhang, R., Ye, J., & Dai, W. (2025) · Angiology · doi:10.1177/00033197251384344 · Cited by 3
“39,40 Furthermore, excessive liver fat accumulation increases the secretion of free fatty acids and adipokines into the systemic circulation, which can induce inflammatory responses and cause endothelial dysfunction, thereby promoting atherosclerosis development.”
Liu, J., Xu, W., Zhang, Y., Jia, Y., Bai, S., Er, L., & Du, R. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05300-8 · Cited by 4
Zhou, X., Ruan, W., Pu, J., Zhang, J., Pang, C., Luo, S., & Li, J. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113107 · Cited by 3
Retinol-binding protein 4 in cardiovascular diseases: mechanisms and therapeutic perspectives
Chen, J., Chen, G., Xu, X., Zhang, J., & Liu, F. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1703840 · Cited by 4
“Notably, IR is an independent risk factor for CVD and early mortality even in the absence of diabetes (108, 109).”
Janssen, J. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052150 · Cited by 2
Otowa‐Suematsu, N., Nakamura, T., Miura, H., Yamada, T., Nishisaka, M., Fukumitsu, H., Katsura, Y., Morita, Y., Asahara, S., & Sakaguchi, K. (2026) · Diabetology International · doi:10.1007/s13340-026-00883-9 · Cited by 5
Eshraghi, R., Bahrami, A., Kosari, M., MD-MPH, K. V., Keyhani, A., Ebrahimi, P., Amini‐Salehi, E., Amani‐Beni, R., Afkhami, S., Yazdani, M. S., et al. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104764 · Cited by 2
Genetic and biomarker modulation of arterial stiffness change in the SardiNIA population cohort
Asefa, N. G., Meirelles, O., Lakatta, E. G., Fiorillo, E., Scuteri, A., Cucca, F., Marongiu, M., Delitala, A., Schlessinger, D., & Launer, L. J. (2024) · Frontiers in Epidemiology · doi:10.3389/fepid.2023.1295209 · Cited by 2
“Insulin resistance can cause the endothelial cells to produce less nitric oxide, a molecule that helps to dilate blood vessels and promote arterial fl exibility (46).”
Henzel, J., Kruk, M. B. P., Kępka, C., Makarewicz‐Wujec, M., Wardziak, Ł., Trochimiuk, P., Krysztofiak, H., Dąbrowski, R., Dzielińska, Z., Maurovich‐Horvat, P., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14060615 · Cited by 3
“…interleukin 1, interleukin 6, tumor necrosis factor alpha, and other pro-inflammatory factors that upregulate the IkappaB-kinase/nuclear factor kappa B (IKK/NF-κ B) and mitogen-activated protein kinase (MAPK) pathways to induce cell apoptosis and ultimately contribute to myocardial injury [23,24].”
BackgroundYang, Y., Yin, X., Zhang, Y., & Ren, L. (2024) · Coronary Artery Disease · doi:10.1097/mca.0000000000001370 · Cited by 2
“Firstly, diabetic patients are more susceptible to atherosclerosis, leading to diffuse and multivessel damage to the coronary arteries [22].”
Influence of medication for lifestyle diseases on thyroid function during health examinations
Tokumaru, M., Ohba, K., Nakamura, M., Goto, Y., Iwaki, T., Matsushita, A., Sasaki, S., Umemura, K., Suda, T., & Takase, H. (2024) · Thyroid Science · doi:10.1016/j.thscie.2024.100014 · Cited by 2
Clinical consequences of the sarcopenic obesity. Part 2. Cardiovascular diseases and osteoporosis
Sheptulina, A. F., Bryk, D. D., Тамерланович, Ц. Т., Yafarova, A. A., Mamutova, E. M., & Drapkina, O. M. (2024) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20242709160 · Cited by 2
Serum Irisin as a Predictor for Peripheral Arterial Disease: Insights from a Clinical Study
Cao, Y., Wei, T., Li, Y., & Duan, H. (2024) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2024.10.017 · Cited by 3
Ayça, B., Yıldız, C., Yüksel, Y., Katkat, F., Arpaç, A., Çağlar, F. N. T., & Erkol, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237271 · Cited by 3
Lai, J., Li, X., Zheng, Y., Liu, Z., Wu, Q., & Cao, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1475204 · Cited by 2
Zhao, B., Yu, Z., Tang, F., Feng, Z., Wang, J., & Wang, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1560577 · Cited by 2
Chen, Y., Fang, C., Zhao, J., Jiang, S., Xu, X., Cui, L., Zhao, R., Ma, X., Lin, T., Yu, H., et al. (2025) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaf219 · Cited by 2
Nguyen, S. B., Olesen, T. B., Domazet, S. L., Kristoffersen, S. F., Nielsen, J. S., Olsen, M. H., & Stidsen, J. V. (2025) · Journal of Human Hypertension · doi:10.1038/s41371-025-01049-x · Cited by 2
“Insulin resistance affects endothelial cells, impairing their ability to produce and release nitric oxide, a vasodilator, which may weaken arterial dilatation and increase SVR [28].”
Atherosclerosis Risk Factors in Patients with Reactive Hypoglycemia
Landowska, M., Żebrowska, A., Fajer, K., Adamek, P., Kruk, A., Kałuża, B., & Franek, E. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s371706 · Cited by 3
“Our results are consistent with the guidelines which indicate that there is causal association between TG-rich lipoproteins (TGRLs), their remnants, and the risk of ASCVD.30 Additional information on the relationship between TG and atherosclerosis was provided by M. Farnier et al. The objective of their review was to…”
BackgroundRuyatkina, L. A., Ruyatkin, D. S., & Iskhakova, I. S. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-7-33-44 · Cited by 2
Çora, A. R., & Çelik, E. (2022) · Investigación Clínica · doi:10.54817/ic.v63n4a04 · Cited by 2
Швед, М. І., Yastremska, I. O., & Овсійчук, Р. М. (2023) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2022.v.i4.13496 · Cited by 4
sobhy, C., Elsayed, M. M., Naoum, L., & Obaya, H. E. (2024) · Benha International Journal of Physical Therapy · doi:10.21608/bijpt.2024.269820.1017 · Cited by 1
Zhou, Q., Cai, X., Jin, A., Jing, J., Wang, M., Wang, S., Mei, L., Meng, X., Li, S., Wei, T., et al. (2024) · Neuroepidemiology · doi:10.1159/000540321 · Cited by 2
“Several studies showed that insulin resistance may contribute to atherosclerotic cardiovascular disease in different populations [7 – 9].”
Atherosclerotic Cardiovascular Disease
Derr, J. N., & Black, A. (2024) · Physician Assistant Clinics · doi:10.1016/j.cpha.2024.11.003 · Cited by 2
FULMINANT MYOCARDITIS-A UNIQUE COMPLICATION OF COVID-19
Ahmed, A., Young, S. K., & Lantz, R. H. (2021) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(21)03378-7 · Cited by 2
Diet induced insulin resistance is due to induction of PTEN expressionPreprint
Mukherjee, R., Pancholi, P., Sharma, M., Solomon, H., Timaul, M. N., Thant, C. N., Mcgriskin, R., Hayatt, O., Markov, V., D’Allara, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.25.645201 · Cited by 2
Chen, Y., Ni, B., Yang, C., Pan, J., & Zhang, J. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1476435 · Cited by 1
“In addition, IR is considered to be one of the hazard factors for atherosclerosis (48).”
An, W., Tang, K., Liu, J., Zheng, W., Li, G., & Xu, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-85825-2 · Cited by 2
Metabolic consequences and nailfold capillary changes in children with familial Mediterranean fever
Hola, A. S. A., Elzayat, R. S., Shehata, W. A., Elashmawy, M. I., Khalaf, N. E., & Zefzaf, H. M. S. E. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-025-01861-8 · Cited by 1
“It is commonly known that insulin resistance promotes endothelial dysfunction and inflammation directly by preventing the synthesis of nitric oxide, which, in turn, causes atherosclerotic cardiovascular disease [25].”
Correlation between Triglyceride-Glucose Index and length of intensive care unit stay in sepsis
Elmas, D., & İnce, M. S. (2025) · Anatolian Current Medical Journal · doi:10.38053/acmj.1644974 · Cited by 1
López‐González, Á. A., Ramírez‐Manent, J. I., Rifá, E. M.-A., Paublini, H., Sánchez, C. M., & López, P. J. T. (2025) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500803 · Cited by 2
Wang, L., Gu, Y., Jiang, G., Lei, C., Zhang, P., Jiang, W., Yang, X., Jin, A., & Deng, Q. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1562361 · Cited by 3
Wang, Z., Wang, S., Li, C., Song, K., Wu, X., Jiang, Y., Zhang, M., & Wang, S. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1625856 · Cited by 1
Turtoi, M., Deleanu, M., Anghelache, M., Voicu, G., Anton, R., Safciuc, F., & Călin, M. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00483 · Cited by 1
Chen, F., Gu, Z., & Peng, R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1615380 · Cited by 2
Renklint, R., Liv, P., Katsoularis, I., Olsson, T., & Otten, J. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70161 · Cited by 1
Zhu, Y. G., Yao, T., Yan, H., & Ke, Q. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1709135 · Cited by 1
Unraveling the Genetic Links: The Impacts of Antidiabetic Drugs on Stroke Risk
Chen, J., Wang, Y., Li, L., & Xu, J. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm40051 · Cited by 1
“The insulin-sensitizing agent pioglitazone exerts anti-atherogenic effects by ameliorating insulin resistance and influencing multiple components of insulin resistance syndrome (INRS) [62].”
Wan, A.-H., Han, Y., Wu, L., Wei, Y., Xiang, X., Chen, Y., Chen, J., Song, A., & Zhao, K. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104474 · Cited by 2
Zhou, M., Zhang, J., Pan, T., Hou, J., Ma, Q., Zhong, S., Wang, L., & Ji, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-31578-x · Cited by 2
“Insulin resistance (IR) is a key driver in the progression of atherosclerosis, contributing to the development of PAD and other cardiovascular conditions 7 .”
Atherosclerosis index and diabetic foot ulcers: an NHANES database investigation
Ju, X., Chen, J., Liu, T., Liu, J., Jiang, D., & Li, Y. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000004570 · Cited by 1
“Hyperglycemia, insulin resistance, and dyslipidemia promote atherosclerosis, increasing the risk of peripheral artery disease (PAD) and diabetic foot ulcers [ 7–10 ] .”
Blachot‐Minassian, B., Paradis, S., Bouyon, S., Boutin, A., Billoir, E., Vial, G., Arnaud, C., Joseph, V., & Belaïdi, E. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.12.031 · Cited by 2
Rong, W., Zhu, Z., Wang, D., & Shang, W. (2026) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2026.108553 · Cited by 1
Li, X., Gong, C., Fu, C., Xia, Q., Zhang, Y., Du, Y., Sun, Y., & Xu, H. (2026) · Purinergic Signalling · doi:10.1007/s11302-025-10117-3 · Cited by 1
Unveiling sex-specific cardiometabolic and adiposity risk profiles for precision prevention
Zuccotti, G., Agnelli, P. O., Labati, L., Cordaro, E., Braghieri, D., Fiorina, P., Bertoli, S., Berra, C., Croci, M., Malighetti, M. E., et al. (2026) · European journal of medical research · doi:10.1186/s40001-026-03878-z · Cited by 1
Sun, X., Yu, X., Shen, J., Wang, M., & Sun, Y. (2026) · Medicine · doi:10.1097/md.0000000000047442 · Cited by 1
Ma, L., Guo, W., Bi, J., Liu, X., Bao, X., Song, G., & Gu, R. (2026) · European journal of medical research · doi:10.1186/s40001-026-04146-w · Cited by 1
Xia, C., Yu, J. S., & Xu, J.-S. (2026) · BMC Public Health · doi:10.1186/s12889-026-27332-1 · Cited by 1
“Insulin resistance (IR) is defined as a pathological state in which target tissues exhibit reduced efficiency in insulin-mediated glucose uptake and utilization, often accompanied by multiple metabolic disorders, including hypertension, dyslipid-emia, hyperglycemia, and obesity [12–14].”
Li, X., Meng, Y., Zhang, L., Li, T., & Yan, G. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03181-5 · Cited by 2
“Insulin resistance (IR) has been increasingly recognized as a central mechanism linking metabolic dysfunction to atherosclerotic cardiovascular disease [5].”
Tu, W., Xu, R., Luo, N., Wu, M., Zhou, Y., & Ning, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1795750 · Cited by 1
“Moreover, IR has also been shown to be related to hypertension (45), a prothrombotic state (46), atrial fibrillation, and vascular smooth muscle cell proliferation, which may explain the predictive value of IR indices for CVD.”
Zawadzki, M., & Karczewska‐Kupczewska, M. (2026) · Cardiovascular Therapeutics · doi:10.1155/cdr/8388511 · Cited by 1
A progeria syndrome links DNA hypermethylation to age-related pathology
Sarni, D., Neary, G., Carroll, P. L., Vink, C. S., Billard, C. V., Isobe, T., Weng, X., Portman, J. R., McCartney, D. L., Heyn, P., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02633-8 · Cited by 4
“Dyslipidemia and insulin resistance predispose to atherosclerosis and type 2 diabetes, respectively 74 .”
Khattib, A., Shmet, M., Ashkar, R., Hayek, T., & Khatib, S. (2026) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000001047 · Cited by 1
Tian, Z., Yan, X., Xue, F., Yang, J., & Li, N. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03260-7 · Cited by 1
“TyG, as a surrogate marker of IR, may reflect metabolic disturbances related to endothelial dysfunction, oxidative stress, and dysregulated lipid metabolism [71–73], which may promote the development and coexistence of CMDs [72–74].”
Li, S., Xu, L., Liang, H., Wang, Y., Shen, Y., & Liu, X. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1842720 · Cited by 1
“IR may promote atherosclerotic CVD through dyslipidemia, endothelial dysfunction, oxidative stress, inflammation, and vascular remodeling (57–59), which are central to the development and progression of CHD (58, 59).”
dos Santos, B. G., Brisnovali, N. F., Haney, C., Coven, M., Sebzevari, H. L., Gaebel, L., Zhang, X., Sun, J., Canfrán‐Duque, A., Rotllán, N., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adv1815 · Cited by 1
Burt, M. G., Mangelsdorf, B. L., Drake, S. M., Swan, M., Padman, S., Vatandoust, S., & Koczwara, B. (2021) · Internal Medicine Journal · doi:10.1111/imj.15469 · Cited by 2
Triglyceride-Glucose Index Could be Used to Predict Severity of Coronary Artery Ectasia
Oflar, E., Ünğan, İ., Yıldız, C., Alp, G. İ. B., Mavi, B., Çağlar, F. N. T., Erciyes, D., & Şahin, A. (2023) · Koşuyolu Heart Journal · doi:10.51645/khj.20239906 · Cited by 1
Biryukova, E. V., & Kileynikov, D. V. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-156 · Cited by 1
Elkhodary, S. B., Atallah, R., & Aboelwafa, H. O. (2023) · International Journal of Medical Arts · doi:10.21608/ijma.2023.211331.1685 · Cited by 1
Varicose vein disease in the context of insulin resistance
Korolenya, V. A., Филипенко, М. Л., & Smetanina, M. A. (2024) · Vessel Plus · doi:10.20517/2574-1209.2024.26 · Cited by 2
Nageeb, R. S., Mohamed, N. M., Soliman, A. S., Ebaid, A. M., & Mohammad, N. A. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00911-y · Cited by 1
Joint association of estimated glucose disposal rate and body mass index with new-onset stroke
Yu, T., Shao, D.-M., Lv, T., & Xiong, Y.-J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1529752 · Cited by 1
Wang, Y., He, X., Wang, Y., & Li, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1584674 · Cited by 1
Farhangi, M. A., Nikniaz, Z., Mirzohreh, S., & Nikniaz, L. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200453 · Cited by 4
“As insulin resistance stimulates the development of cardiovascular disease [38], screening, prevention, and designing specific interventions for children with high HOMA-IR levels should be a priority.”
Aydın, C. (2021) · Cardiovascular Surgery and Interventions · doi:10.5606/e-cvsi.2021.1192 · Cited by 1
“For many years, insulin resistance and hypertriglyceridemia have been related to metabolic disorders, type 2 diabetes, and atherosclerotic cardiovascular diseases.[16-19] In the onset of diabetes, insulin resistance develops first.”
BackgroundHeidari, M., Hajizadeh‐Sharafabad, F., & Alizadeh, M. (2022) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2022.09.004 · Cited by 1
Yu, S., Guo, X., Li, G., Yang, H., Zheng, L., & Sun, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.995128 · Cited by 1
Chen, W., Shi, S., Tu, J., Liao, L., Liao, Y., Chen, K., Chen, L., & Huang, R. (2022) · Research Square · doi:10.21203/rs.3.rs-1630729/v1 · Cited by 1
Diet induced insulin resistance is due to induction of PTEN expressionPreprint
Rosen, N. X., Mukherjee, R., Pancholi, P., Sharma, M., Solomon, H., Timaul, M. N., Thant, C. N., Mcgriskin, R., Hayatt, O., Markov, V., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4021885/v1 · Cited by 3
Accelerated Pace of Atherosclerosis in Steatotic Liver Disease: Implications for Risk Stratification
Sposito, A. C. (2024) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.124.017376 · Cited by 1
Hess, B. J. M. (2020) · Urologie in der Praxis · doi:10.1007/s41973-020-00113-y
Jia, L.-Y., Li, J., Cao, G., Meng, Z., Gan, L., Li, J., Lan, X., Yang, C.-L., & Zhang, C.-F. (2020) · doi:10.21203/rs.3.rs-21814/v1
“Based on the results of biological functional analysis, there are a variety of pathways like PI3K-Akt signaling pathway, MAPK signaling pathway, FoxO signaling pathway[44], Ras signaling pathway[45] and Endocrine resistance[46], are robustly correlated with the pathogenesis of CHD.”
BackgroundJak postupovat v boji s inzulinovou rezistencí u pacientů s DM 2. typu
Haluzı́k, M. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.128
Fu, L., Tai, S., Sun, J., Zhang, N., Zhou, Y., Xing, Z., Wang, Y., & Zhou, S. (2021) · Research Square · doi:10.21203/rs.3.rs-960363/v1
Hess, B. J. M. (2021) · Journal für Urologie und Urogynäkologie/Österreich · doi:10.1007/s41972-021-00150-w
Cortés, A. M. T. (2021) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/178231
Insulin, Nobel laureates and The Journal of Physiology
Mittendorfer, B. (2022) · The Journal of Physiology · doi:10.1113/jp282823
“Researchers’ interest in insulin has not waned and it is now well established that the effects of insulin reach well beyond its essential role in regulating blood glucose (James et al. 2017; Di Pino & DeFronzo, 2019; Vigneri et al. 2020).”
BackgroundEvaluation of the Relationship Between Saphenous Vein Graft Disease and Triglyceride Glucose Index
Acele, A., & Abacıoğlu, Ö. Ö. (2021) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2021.65624
“It is known that insulin resistance is effective in the development of atherosclerosis, and it has been shown that the risk can be reduced with treatments that reduce insulin resistance 15 .”
Liu, C., Zhao, Q., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Liu, X., & Zhou, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1555190/v1
Wan, Y., Tabung, F. K., Lee, D. H., Fung, T. T., Willett, W. C., & Giovannucci, E. L. (2021) · doi:10.2337/figshare.16906060.v1
The Effect of Blood Sugar Fasting Levels on Diabetic Dyslipidemia
Yasmin, R., Ahmed, A., Javed, A., Asim, M., Shabbir, R., Mushtaq, S., & Irshad, F. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22164360
METABOLIC CHANGES / INSULIN RESISTANCE IN TUBERCULOSIS PATIENTS: CAUSE OR EFFECT: review
SHVETS, O. M., Shevchenko, O. S., Pіskur, Z. I., Stepanenko, H., & Pohorielova, O. (2022) · Inter Collegas · doi:10.35339/ic.8.4.232-237 · Cited by 3
Liu, J., Zhang, L., Zhang, Y., & Deng, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1710298/v1
Sleem, H. A., Hamed, H. I., El‐Saeed, R. A., & Youssef, M. M. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.9668
Ultrasonic characteristics and influencing factors of atherosclerosis in diabetic patients.
Zhao, Y., Lin, S., Chen, K., Chen, D., & Lai, J. (2022) · PubMed Central
Serum Apelin-12 as a Novel Marker of Metabolic Inflammatory Syndrome in elderly ChinesePreprint
Wang, X., Wang, J., Ren, J., Zhang, X., Wang, J., Wang, Y., Hu, Y., Zhang, Y., He, C., Xue, W.-J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1767907/v1
Liu, C., Liu, X., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Zhao, Q., & Zhou, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1881958/v1
Metadata
- Authors
- Di Pino, A., & DeFronzo, R. A.
- Affiliations
- Diabetes Division, University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, Texas
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- DeFronzo, Ralph A
- ORCID
- DeFronzo, Ralph A
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-05-03
- Volume
- 40
- Issue
- 6
- Pages
- 1447-1467
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC7445419
- OpenAlex
- W2945554427
- Cited by
- 535
- References
- 344
- Citations by year
- 2026: 77 · 2025: 117 · 2024: 95 · 2023: 76 · 2022: 89 · 2021: 55 · 2020: 22 · 2019: 4
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK-24092-38)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin resistance, atherosclerosis, type 2 diabetes, metabolic syndrome, insulin sensitizers, thiazolidinediones, pioglitazone, cardiovascular risk, macrovascular complications, cardiovascular outcome trials, antihyperglycemic medications, cardiometabolic risk factors
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Insulin Resistance, Thiazolidinediones, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.